Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Munster, P.
872  Ergebnisse:
Personensuche X
?
1

205P VERITAC update: Phase II study of ARV-471, a PROteolys..:

Hurvitz, S.A. ; Schott, A. ; Ma, C.X....
ESMO Open.  8 (2023)  1 - p. 101394 , 2023
Link: https://doi.org/10.1016/..
 
?
2

P253 ARV-471, a PROTAC® estrogen receptor (ER) degrader in ..:

Hurvitz, S.A ; Schott, A.F ; Ma, C....
The Breast.  68 (2023)  - p. S116 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Impact of Optical Connectors on QKD Transmission:

Klíčník, O. ; Münster, P. ; Horváth, T.
Fiber and Integrated Optics.  42 (2023)  6 - p. 219-231 , 2023
Link: https://doi.org/10.1080/..
 
?
4

The December 2014 glaze event in the Czech Republic: predic..:

Zahradníček, P. ; Münster, P. ; Bíl, M....
Weather.  73 (2018)  12 - p. 375-382 , 2018
Link: https://doi.org/10.1002/..
 
?
5

Topacio: Preliminary activity and safety in patients (pts) ..:

Konstantinopoulos, P.A. ; Munster, P. ; Forero-Torez, A....
Gynecologic Oncology.  149 (2018)  - p. 246 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Safety and antitumor activity of the anti-PD-1 antibody pem..:

Ott, P.A. ; Piha-Paul, S.A. ; Munster, P....
Annals of Oncology.  28 (2017)  5 - p. 1036-1041 , 2017
Link: https://doi.org/10.1093/..
 
?
7

Phase 1 study of CB-839, a small molecule inhibitor of glut..:

Meric-Bernstam, F. ; Tannir, N. ; Harding, J....
European Journal of Cancer.  69 (2016)  - p. S12-S13 , 2016
Link: https://doi.org/10.1016/..
 
?
8

Initial results from a phase 1a/b study of OMP-131R10, a fi..:

Bendell, J. ; Eckhardt, G.S. ; Hochster, H.S....
European Journal of Cancer.  69 (2016)  - p. S29-S30 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Distribution ofMycobacterium aviumsubsp.paratuberculosisin ..:

Fechner, K. ; Schäfer, J. ; Wiegel, C....
Transboundary and Emerging Diseases.  64 (2015)  3 - p. 916-928 , 2015
Link: https://doi.org/10.1111/..
 
?
10

500 Pembrolizumab (MK-3475) for PD-L1-positive squamous cel..:

Ott, P.A. ; Piha-Paul, S.A. ; Munster, P....
European Journal of Cancer.  51 (2015)  - p. S102 , 2015
Link: https://doi.org/10.1016/..
 
?
11

2 Safety and early evidence of activity of a first-in-human..:

Patnaik, A. ; LoRusso, P. ; Munster, P....
European Journal of Cancer.  50 (2014)  - p. 7 , 2014
Link: https://doi.org/10.1016/..
 
?
12

A phase I, randomized, open-label study of the multiple-dos..:

Grippo, J. F. ; Zhang, W. ; Heinzmann, D....
Cancer Chemotherapy and Pharmacology.  73 (2013)  1 - p. 103-111 , 2013
Link: https://doi.org/10.1007/..
 
?
13

437 Biomarker Development for the Pharmacodynamic Assessmen..:

Wong, L. ; Liu, Y. ; Wu, X....
European Journal of Cancer.  48 (2012)  - p. 136 , 2012
Link: https://doi.org/10.1016/..
 
?
14

A Longitudinal Study to Characterize the Distribution Patte..:

Münster, P. ; Völkel, I. ; Wemheuer, W....
Transboundary and Emerging Diseases.  60 (2012)  2 - p. 175-187 , 2012
Link: https://doi.org/10.1111/..
 
?
15

1201 ORAL Early Studies of the Safety, Pharmacokinetics (PK..:

Rosen, L. ; Munster, P. ; Bai, S....
European Journal of Cancer.  47 (2011)  - p. S144 , 2011
Link: https://doi.org/10.1016/..
 
1-15